Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Lineage Cell Therapeutics, Inc. (LCTX)

Biological Products, (no Disgnostic Substances)

https://www.lineagecell.com

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cell transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

2173 SALK AVENUE, SUITE 200
CARLSBAD, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/05/1992

Market Cap

162,116,565

Shares Outstanding

174,990,000

Weighted SO

174,986,671

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

MAIA --.--%

ARMP --.--%

FREQ --.--%

PRTG --.--%

AGE --.--%

CVKD --.--%

ICCC --.--%

ONTTF --.--%

REPL --.--%

Beta

1.2960

Last Div

0.0000

Range

0.77-1.61

Chg

-0.0052

Avg Vol

864961

Mkt Cap

162116565

Exch

AMEX

Country

US

Phone

442 287 8990

DCF Diff

2.5880

DCF

-1.2930

Div Yield

0.0000

P/S

26.2070

EV Multiple

-5.4468

P/FV

2.3733

Div Yield %

0.0000

P/E

-6.7018

PEG

-0.2369

Payout

0.0000

Current Ratio

2.6442

Quick Ratio

2.6442

Cash Ratio

1.9392

DSO

13.8660

DIO

0.0000

Op Cycle

13.8660

DPO

823.0595

CCC

-809.1935

Gross Margin

0.8288

Op Margin

-4.1376

Pretax Margin

-3.9125

Net Margin

-3.9100

Eff Tax Rate

0.0007

ROA

-0.2353

ROE

-0.3554

ROCE

-0.2924

NI/EBT

0.9993

EBT/EBIT

0.9456

EBIT/Rev

-4.1376

Debt Ratio

0.0287

D/E

0.0432

LT Debt/Cap

0.0262

Total Debt/Cap

0.0414

Int Coverage

-58.8391

CF/Debt

-7.4602

Equity Multi

1.5052

Rec Turnover

26.3234

Pay Turnover

0.4435

Inv Turnover

0.0000

FA Turnover

1.3442

Asset Turnover

0.0602

OCF/Share

-0.1166

FCF/Share

-0.1183

Cash/Share

0.2039

OCF/Sales

-3.5588

FCF/OCF

1.0144

CF Coverage

-7.4602

ST Coverage

-19.7444

CapEx Coverage

-69.2296

Div&CapEx Cov

-69.2296

P/BV

2.3733

P/B

2.3733

P/S

26.2070

P/E

-6.7018

P/FCF

-7.2591

P/OCF

-7.3630

P/CF

-7.3630

PEG

-0.2369

P/S

26.2070

EV Multiple

-5.4468

P/FV

2.3733

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Sep 21, 22:36 W.P. Carey: Buy, Sell, or Hold? MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.08 12/15/2003 11/30/-0001 11/30/-0001 11/30/-0001